Halozyme eyes microparticles in $900m Elektrofi acquisition
Halozyme will expand its drug delivery offerings with a high-concentration biologics platform.
Drug Manufacturers
Eli Lilly to build $6.5bn orforglipron production site in Texas
Eli Lilly picks Virginia for $5bn drug manufacturing plant
Opadry complete film coating system: 45 years of trust, innovation and performance
J&J signs $2bn incumbency deal at CDMO Fujifilm’s new hub
Trump targets bolstering of US emergency drug reserve
Uncertainty looms over FDA scheme to boost US manufacturing
Manufacturing issues at Novo facility disrupt Regeneron drug review
